Published in BMC Nephrol on October 08, 2012
CKD Prevalence Varies across the European General Population. J Am Soc Nephrol (2015) 1.10
Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review. Nephrol Dial Transplant (2015) 0.94
A Risk Assessment of the Jaffe vs Enzymatic Method for Creatinine Measurement in an Outpatient Population. PLoS One (2015) 0.81
Routine serum creatinine measurements: how well do we perform? BMC Nephrol (2015) 0.81
A temporary loop ileostomy affects renal function. Int J Colorectal Dis (2014) 0.79
Critical serum creatinine values in very preterm newborns. PLoS One (2013) 0.78
Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children. Clin Pharmacokinet (2015) 0.76
The role of laboratory testing in detection and classification of chronic kidney disease: national recommendations. Biochem Med (Zagreb) (2017) 0.75
Impact of creatinine methodology on glomerular filtration rate estimation in diabetes. World J Diabetes (2017) 0.75
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis (2002) 81.62
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81
Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med (2006) 20.27
Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem (2007) 13.80
Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem (2005) 8.93
Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis (2002) 7.03
Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis (2007) 5.06
Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis (2010) 3.37
Factors influencing the assay of creatinine. Ann Clin Biochem (1975) 1.63
Candidate reference methods for determining target values for cholesterol, creatinine, uric acid, and glucose in external quality assessment and internal accuracy control. I. Method setup. Clin Chem (1993) 1.60
Estimating the prevalence of low glomerular filtration rate requires attention to the creatinine assay calibration. J Am Soc Nephrol (2002) 1.43
Traceability, reference systems and result comparability. Clin Biochem Rev (2007) 1.33
Implementation of reference systems in laboratory medicine. Clin Chem (2000) 1.33
Variability of creatinine measurements in clinical laboratories: results from the CRIC study. Am J Nephrol (2010) 1.27
The future of laboratory medicine: understanding the new pressures. Clin Biochem Rev (2004) 1.16
Standardization in laboratory medicine: new challenges. Clin Chim Acta (2005) 1.13
Prime time for enzymatic creatinine methods in pediatrics. Clin Chem (2009) 1.08
Creatinine assays: time for action? Ann Clin Biochem (2002) 1.05
The importance of metrological traceability on the validity of creatinine measurement as an index of renal function. Clin Chem Lab Med (2006) 1.02
Enzymatic assays for creatinine: time for action. Clin Chem Lab Med (2008) 0.97
A multicentric evaluation of IDMS-traceable creatinine enzymatic assays. Clin Chim Acta (2011) 0.97
Trueness verification of actual creatinine assays in the European market demonstrates a disappointing variability that needs substantial improvement. An international study in the framework of the EC4 creatinine standardization working group. Clin Chem Lab Med (2008) 0.94
Impact of reference materials on accuracy in clinical chemistry. Clin Biochem (1998) 0.91
The new European directive on in vitro diagnostics. Clin Chem Lab Med (2003) 0.89
Certification of creatinine in a human serum reference material by GC-MS and LC-MS. Clin Chem (2007) 0.88
Creatinine measurement proficiency testing: assignment of matrix-adjusted ID GC-MS target values. Clin Chem (1997) 0.81
Candidate reference methods for determining target values for cholesterol, creatinine, uric acid, and glucose in external quality assessment and internal accuracy control. II. Method transfer. Clin Chem (1993) 0.80
[Employing age-related cut-off values results in fewer patients with renal impairment in secondary care]. Ned Tijdschr Geneeskd (2011) 0.78
Negative interference in a kinetic Jaffé method for serum creatinine determination. Ann Clin Biochem (1988) 0.77
Accuracy-based assessment of proficiency testing results with serum from single donations: possibilities and limitations. Clin Chem (1996) 0.77
Age and association of kidney measures with mortality and end-stage renal disease. JAMA (2012) 7.20
Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med (2011) 6.34
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet (2012) 5.10
IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem (2004) 4.02
Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med (2002) 3.75
Genetic loci influencing kidney function and chronic kidney disease. Nat Genet (2010) 3.75
Epidemiology of contrast material-induced nephropathy in the era of hydration. Radiology (2012) 3.52
Can diabetes management be safely transferred to practice nurses in a primary care setting? A randomised controlled trial. J Clin Nurs (2011) 2.94
Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care (2009) 2.90
Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA (2009) 2.85
Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children. Clin J Am Soc Nephrol (2009) 2.84
Job satisfaction among general practitioners: a systematic literature review. Eur J Gen Pract (2006) 2.77
Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases. Endocr Relat Cancer (2007) 2.63
Manipulative therapy in addition to usual medical care for patients with shoulder dysfunction and pain: a randomized, controlled trial. Ann Intern Med (2004) 2.58
Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial. J Am Coll Cardiol (2003) 2.40
Effect of device-guided breathing exercises on blood pressure in hypertensive patients with type 2 diabetes mellitus: a randomized controlled trial. J Hypertens (2007) 2.26
Device-guided breathing as treatment for hypertension in type 2 diabetes mellitus: a randomized, double-blind, sham-controlled trial. JAMA Intern Med (2013) 2.16
Estimating glomerular filtration rate: Cockcroft-Gault and Modification of Diet in Renal Disease formulas compared to renal inulin clearance. Clin J Am Soc Nephrol (2009) 2.12
Proximal tubular cells contain a phenotypically distinct, scattered cell population involved in tubular regeneration. J Pathol (2013) 2.12
Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention. Circulation (2011) 2.01
Prognostic value of troponin after elective percutaneous coronary intervention: A meta-analysis. Catheter Cardiovasc Interv (2008) 1.99
Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy. J Am Soc Nephrol (2013) 1.94
Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome. J Am Soc Nephrol (2013) 1.90
Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells. J Am Soc Nephrol (2009) 1.85
Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J Am Soc Nephrol (2011) 1.80
Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood (2011) 1.79
Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening. J Am Soc Nephrol (2006) 1.78
Association of cognitive function with albuminuria and eGFR in the general population. Clin J Am Soc Nephrol (2011) 1.77
Proficiency testing/external quality assessment: current challenges and future directions. Clin Chem (2011) 1.75
Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation. Nephrol Dial Transplant (2002) 1.74
Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders. Clin Chem (2010) 1.68
Prognostic value of risk score and urinary markers in idiopathic membranous nephropathy. Clin J Am Soc Nephrol (2012) 1.64
Prediction of mortality in type 2 diabetes from health-related quality of life (ZODIAC-4). Diabetes Care (2008) 1.62
Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications. Diabetes Care (2007) 1.59
Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases. PLoS Genet (2010) 1.57
Idiopathic membranous nephropathy: outline and rationale of a treatment strategy. Am J Kidney Dis (2005) 1.56
Serum-soluble urokinase receptor concentration in primary FSGS. Kidney Int (2012) 1.55
The relationship between glycaemic control and mortality in patients with type 2 diabetes in general practice (ZODIAC-11). Br J Gen Pract (2010) 1.54
Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome. Kidney Int (2010) 1.52
Oxidative stress in patients with end-stage renal disease prior to the start of renal replacement therapy. Nephron Clin Pract (2004) 1.48
Validation of the kidney failure risk equation in European CKD patients. Nephrol Dial Transplant (2013) 1.48
Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for prevention. J Nucl Med (2010) 1.46
Familial Aggregation between the 14th and 21st Century and Type 2 Diabetes Risk in an Isolated Dutch Population. PLoS One (2015) 1.43
Serum creatinine is a poor marker of GFR in nephrotic syndrome. Nephrol Dial Transplant (2005) 1.42
Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: a randomized, double-blind, placebo-controlled trial. Diabetes Care (2006) 1.40
Abnormal vitamin D metabolism and loss of bone mass after renal transplantation. Nephron Clin Pract (2003) 1.39
Pre- and postoperative accuracy and safety of a real-time continuous glucose monitoring system in cardiac surgical patients: a randomized pilot study. Diabetes Technol Ther (2009) 1.38
Continuous intraperitoneal insulin infusion versus subcutaneous insulin therapy in the treatment of type 1 diabetes: effects on glycemic variability. Diabetes Technol Ther (2015) 1.38
Gelatin-based plasma expander effectively reduces renal uptake of 111In-octreotide in mice and rats. J Nucl Med (2006) 1.37
Renal uptake of radiolabeled octreotide in human subjects is efficiently inhibited by succinylated gelatin. J Nucl Med (2006) 1.34
Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathy. Clin J Am Soc Nephrol (2011) 1.30
MASTERPLAN: study of the role of nurse practitioners in a multifactorial intervention to reduce cardiovascular risk in chronic kidney disease patients. J Nephrol (2008) 1.30
Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. Am J Pathol (2011) 1.30
Genetic causes of focal segmental glomerulosclerosis: implications for clinical practice. Nephrol Dial Transplant (2012) 1.29
Alkylating agents in membranous nephropathy: efficacy proven beyond doubt. Nephrol Dial Transplant (2010) 1.28
Lower blood pressure associated with higher mortality in elderly diabetic patients (ZODIAC-12). Age Ageing (2010) 1.26
Multifactorial intervention with nurse practitioners does not change cardiovascular outcomes in patients with chronic kidney disease. Kidney Int (2012) 1.24
Health-related quality of life and mortality in a general and elderly population of patients with type 2 diabetes (ZODIAC-18). Diabetes Care (2010) 1.24
Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate. Nephrol Dial Transplant (2009) 1.22
Call for a re-evaluation of the American Heart Association's standpoint concerning device-guided slow breathing using the RESPeRATE device. Hypertension (2013) 1.20
Pathological variants of focal segmental glomerulosclerosis in an adult Dutch population--epidemiology and outcome. Nephrol Dial Transplant (2007) 1.17
Management of patients with membranous nephropathy. Nephrol Dial Transplant (2011) 1.17
Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis. Kidney Int (2008) 1.14
Serum suPAR in patients with FSGS: trash or treasure? Pediatr Nephrol (2013) 1.13
Self-monitoring of blood glucose: the use of the first or the second drop of blood. Diabetes Care (2011) 1.12
The parietal epithelial cell: a key player in the pathogenesis of focal segmental glomerulosclerosis in Thy-1.1 transgenic mice. J Am Soc Nephrol (2004) 1.12
High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy. Nephrol Dial Transplant (2011) 1.12
Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: response to Welschen et al. Diabetes Care (2005) 1.12
Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathy. PLoS One (2010) 1.12
Amiloride blocks lithium entry through the sodium channel thereby attenuating the resultant nephrogenic diabetes insipidus. Kidney Int (2009) 1.11
Introduction of a cyclophosphamide-based treatment strategy and the risk of ESRD in patients with idiopathic membranous nephropathy: a nationwide survey in the Netherlands. Nephrol Dial Transplant (2008) 1.10
Trueness verification and traceability assessment of results from commercial systems for measurement of six enzyme activities in serum: an international study in the EC4 framework of the Calibration 2000 project. Clin Chim Acta (2006) 1.10
Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy. Nephrol Dial Transplant (2008) 1.10
Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial. Nephrol Dial Transplant (2009) 1.09
Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease? Nephrol Dial Transplant (2008) 1.07
Initial implementation of a web-based consultation process for patients with chronic kidney disease. Ann Fam Med (2013) 1.07
Preregistration of study design and non-inferiority margin. Lancet (2013) 1.07